ESHRE 2024 - Main programme


Please take the 
time zone differences into account! Times are shown in CE(S)T – Central European (Summer) Time.

>> Monday      >> Tuesday      >> Wednesday
>> Monday >> Friday >> Saturday >> Sunday >> Monday >> Tuesday >> Wednesday


Tuesday 09 July 2024

08:30 - 09:30
Session 34: Live imaging of preimplantation embryos
Chairs
Aisling Ahlstrom, Sweden
M.H.E.C. Pieters, The Netherlands
08:30 - 08:50
Non-invasive evaluation of embryo metabolic activity through hyperspectral microscopy
Kylie Dunning, Australia
08:50 - 09:00
Discussion
09:00 - 09:20
Instructions for assembly of early mammalian embryos
Nicolas Plachta, Singapore Rep. of
09:20 - 09:30
Discussion

08:30 - 09:30
Session 35: Fertility in transmasculine people
Chairs
Caroline Roelens, Belgium
Taghride Dahhan, The Netherlands
08:30 - 08:50
Ovarian function in transmasculine people
Molly Moravek, U.S.A.
08:50 - 09:00
Discussion
09:00 - 09:20
Fertility in transmasculine people
Norah Van Mello, The Netherlands
09:20 - 09:30
Discussion

08:30 - 09:30
Session 36: Novel technology and concepts for preimplantation and prenatal testing
Chairs
Francesco Fiorentino, Italy
Jitske Eliveld, The Netherlands
08:30 - 08:50
Advances in PGT diagnostics - technologies beyond copy number
Christian Simon Ottolini, Italy
08:50 - 09:00
Discussion
09:00 - 09:20
Advances in prenatal diagnosis for the follow-up of PGT pregnancies
Masoud Zamani Esteki, The Netherlands
09:20 - 09:30
Discussion

08:30 - 09:30
Session 37: Channeling sperm motility
Chairs
Verena Nordhoff, Germany
Astrid Cantineau, The Netherlands
08:30 - 08:50
Architecture and in situ arrangement of the CatSper-channel complex in the sperm flagellum
Jean-Ju Chung, U.S.A.
08:50 - 09:00
Discussion
09:00 - 09:20
The role of CatSper in male infertility - from bench to bedsite and back
Timo Strünker, Germany
09:20 - 09:30
Discussion

08:30 - 09:30
Session 38: European and Global ART Monitoring
Chairs
Diane De Neubourg, Belgium
Markus S. Kupka, Germany
08:30 - 09:00
Assisted Reproductive Technology (ART) in Europe 2021 and development of a strategy of vigilance: Preliminary results generated from European registers by the ESHRE EIM Consortium
Jesper M.J. Smeenk, The Netherlands
09:00 - 09:15
ICMART Preliminary World Report 2020
G. David Adamson, U.S.A.
09:15 - 09:30
Using real world data from ART registries in the health education of patients
Fernando Zegers-Hochschild, Chile

08:30 - 09:30
Session 39: The fallopian tube surgery in the era of ART
Chairs
María Isabel Acien, Spain
Kim Dreyer, The Netherlands
08:30 - 08:50
What is the role of tubal surgery in the era of ART?
Antoine Watrelot, France
08:50 - 09:00
Discussion
09:00 - 09:20
How to evaluate the tubal function before and during surgery
Kamal Ojha, United Kingdom
09:20 - 09:30
Discussion

08:30 - 09:30
Session 40: Poster discussion session - Ethics & Law
Seppe Segers, Belgium
08:30 - 08:45
Redefining elective co-parenting: a systematic assessment of concepts and definitions found in the literature and a recommendation for new terminology
Lei Decappelle, Belgium
08:45 - 09:00
From cross-border reproduction to embryos and gametes transit: the peculiar italian case examined from ethical, legal, and comparative standpoint
Sara Dalla Costa, Italy
09:00 - 09:15
Ready for polygenic risk scores? An analysis of regulation of preimplantation genetic testing in seven European countries
Maria Siermann, Belgium
09:15 - 09:30
Identifying essential information for a valid informed consent (IC) of egg donors: An international Delphi study
Lara Jacxsens, Belgium

09:30 - 10:00
Coffee break in the exhibit hall

09:30 - 10:30
IBSA: A transatlantic perspectives to optimize ART results through hCG-driven LH activity
Chair
Dominique De Ziegler, France
09:30 - 09:35
Welcome and introduction
Dominique De Ziegler, France
09:35 - 10:00
hCG-driven LH activity: rationale for a need and clinical options
Ernesto Bosch Aparicio, Spain
10:00 - 10:25
Does the timing of LH activity and the FSH/LH ratio matter?
James P Toner, U.S.A.
10:25 - 10:30
Take home messages
Dominique De Ziegler, France

10:00 - 11:30
Session 41: Planet blastocyst
Chairs
Debbie Montjean, Canada
Samantha Francina Huixian de Witte, The Netherlands
10:00 - 10:15
Blastocyst spent culture medium metabolite levels and reproductive outcomes
Funda Göde, Turkey
10:15 - 10:30
Blastocyst expansion speed assay: a putative artificial intelligence-powered tool for embryo selection. Retrospective study involving 2184 blastocysts and 786 PGT-A cycles
Federica Innocenti, Italy
10:30 - 10:45
Can embryo re-expansion pattern post-biopsy for PGT-A have a predictive value on the outcome?
Ibrahim Elkhatib, United Arab Emirates
10:45 - 11:00
Live birth of Day 7 blastocyst transfers. Another chance to succeed.
Marcela Calonge, U.S.A.
11:00 - 11:15
The spatial conformational features of blastocysts can serve as a new basis for selection
Bo Huang, China
11:15 - 11:30
A novel approach to predicting the potential of a blastocyst using untargeted spectral analysis of spent culture medium and machine learning
Alexey Gryaznov, Russia C.I.S.

10:00 - 11:30
Session 42: (De)regulation of spermatogenesis process
Chairs
Nicolás Garrido Puchalt, Spain
Andreas Meißner, The Netherlands
10:00 - 10:15
A systematic spatial HiPlex proteomics exploration of human testicular tissues from birth to adulthood
Shiyan Tang, United Kingdom
10:15 - 10:30
Retinoic acid has an essential role in meiotic progression beyond the zygotene stage in mouse testis
Diana CONDREA, France
10:30 - 10:45
Down regulation of Clock gene in testicle may affect energy metabolism of sertoli cell
Xudong Shan, China
10:45 - 11:00
The consequences of paternal pre-conceptional health for offspring health and pregnancy outcomes: involvement of the germ-cell epigenome and non-germ cell factors
Raffaele Teperino, Germany
11:00 - 11:15
A comprehensive evaluation of spermatogenesis-related genes identifies novel common and rare risk loci for idiopathic severe spermatogenic failure
F. David Carmona, Spain
11:15 - 11:30
Functional characterisation of three human male infertility associated X-linked genes using Drosophila melanogaster as model organism
Avinash Gaikwad, Germany

10:00 - 11:30
Session 44: Endometriosis, endometrial disorders and infertility: from bench to bedside
Chairs
Stacey Missmer, U.S.A.
Noortje Van Den Boogaard, The Netherlands
10:00 - 10:15
Serum Progesterone levels do not differ between patients with endometriosis and unaffected patients who conceive after Hormone Replacement Therapy-Frozen Embryo Transfer (HRT-FET) cycles
Chloe Maignien, France
10:15 - 10:30
Role of serum progesterone levels and subcutaneous progesterone supplementation in endometriosis patients undergoing Artificial Cycle Frozen Embryo Transfer
Noémie Sachs-Guedj, Switzerland
10:30 - 10:45
Does presence of endometriosis adversely affect oocyte morphology? Evaluation of a large number of oocytes obtained from endometriosis patients, 27204 oocytes
Semra Kahraman, Turkey
10:45 - 11:00
The Endometriosis Longitudinal Fertility Study (ELFS): Outcomes for women with moderate or severe endometriosis who are trying to conceive
Vanessa Ross, United Kingdom
11:00 - 11:15
Identification and validation of RPL7 and RCCD1 as potential biomarkers associated with immune infiltration in patients with thin endometrium
Jiani Sun, China
11:15 - 11:30
Endometrial Preparation Using CONCEIVF Algorithm with Intrauterine and Sub-Endometrial Endosera Administration for Enhanced Pregnancy Rates in Women with Thin Endometrium
Dr Bharathi Rajanna, India

10:00 - 11:30
Session 45: Advancing clinical PGT-A: steps towards an evidence-based consensus
Chairs
Antonio Capalbo, Italy
Simone Broer, The Netherlands
10:00 - 10:15
Pre-implantation genetic testing for aneuploidies (PGT-A) improves reproductive outcomes in advanced maternal age patients undergoing IVF/ICSI: a multicentre retrospective cohort study with propensity score matching
Maria Flores Casteleiro Alves, Portugal
10:15 - 10:30
Clinical utility of preimplantation genetic testing for aneuploidy origin (PGT-AO) to enhance embryo selection for monogenic disorders: a retrospective pan-country integrative genomic and clinical study
Rick Essers, The Netherlands
10:30 - 10:45
Chromosomal, gestational, and neonatal outcomes of mosaic embryos: analysis of 3074 cases from the International Registry of Mosaic Embryo
Francesca Spinella, Italy
10:45 - 11:00
Limited utility of mosaicism reporting in PGT-A: independent confirmation from a European multisite, double-blinded analysis including 4293 embryo transfers following the first US experience.
Dhruti Babariya, United Kingdom
11:00 - 11:15
Trophectoderm biopsy for pre-implantation genetic testing (PGT) does not increase rates of placental abnormalities among singleton pregnancies conceived with in-vitro fertilization (IVF).
Evelyn Minis, U.S.A.
11:15 - 11:30
The effect of growth hormone on the euploid rate and morphokinetic signature of blastocysts in patients with advanced maternal age : a randomized controlled trial
YILUN SUI, China

10:00 - 11:30
Session 46: Socially and environmentally sustainable reproductive care
Chairs
Denisa Marina Protopopescu, Romania
Taghride Dahhan, The Netherlands
10:00 - 10:15
Social disparities in achieving a live birth after initiating ART treatment: a national register-based study among women in Denmark.
Rikke Uggerhøj, Denmark
10:15 - 10:30
Domestic and cross-border reproductive care among same-sex male intended parents: comparing live birth rates (LBRs) in a national retrospective cohort in the United States (U.S.)
Brent Monseur, U.S.A.
10:30 - 10:45
Age at menarche is a marker for increased time to pregnancy
Mari Warp, Norway
10:45 - 11:00
#Infertility: A systematic review of information available on social media platforms
Kugajeevan Vigneswaran, United Kingdom
11:00 - 11:15
Ethnic disparity in the use of treatment with assisted reproductive technologies in Denmark
Sofie Østergaard, Denmark
11:15 - 11:30
The effect of ambient exposure to air pollutants on live birth rates in frozen embryo transfer cycles.
Nikolaos P. Polyzos, Spain

10:00 - 11:30
Session 47: Poster discussion session - Reproductive endocrinology
Samuel Dos Santos-Ribeiro, Portugal
10:00 - 10:15
A retrospective cohort study of the stability of ovarian reserve in women with Turner Syndrome (TS) and spontaneous menstruation
Zachary Nash, United Kingdom
10:15 - 10:30
Mild ovarian stimulation using the aromatase inhibitor letrozole (LTZ) is an effective stimulation protocol to obtain euploid blastocysts for women of an advanced maternal age
Takashi Horikawa, Japan
10:30 - 10:45
A randomized trial to compare the live birth rate following the progestin-primed ovarian stimulation versus the antagonist protocol in women with anticipated high ovarian responses
Ernest Ng, China
10:45 - 11:00
Association between PCOS phenotype-D and euploid blastocyst rate per cohort of inseminated oocytes: a matched case-control study versus idiopathic infertile women.
Gemma Fabozzi, Italy
11:00 - 11:15
Prognostic statistical model of age-specific anti-Müllerian hormone (AMH) decrease based on hormone values of 23,528 women.
Martin Vladimirov, Bulgaria
11:15 - 11:30
Application of biomarkers in obese infertile women: a genetic tool for a personalized treatment
Charalampos Voros, Greece

11:15 - 12:15
Organon: Policy Solutions to Improve Access to Fertility Treatment and Optimise Patient Care
Chair
Hannah Armstrong, United Kingdom
11:25 - 11:50
Panelists
Co-speaker[0000788900] Panelists
G. David Adamson, U.S.A.
Co-speaker[0000788940] Presentation 2
Ying C. Cheong, United Kingdom
Co-speaker[0000788900] Panelists
Rui Ferriani, Brazil
Co-speaker[0000788900] Panelists
Georg Griesinger, Germany
Co-speaker[0000788900] Panelists
Søren Ziebe, Denmark
12:10 - 12:15
Closing by chair

11:45 - 13:00
Merck KGaA: Ageing and infertility: Overcoming the biological clock
Chairs
Frank J. Broekmans, The Netherlands
11:45 - 11:50
Welcome
Monica Lispi, Germany
11:50 - 12:02
Global Fertility landscape
Tamara Hunter, Australia
12:02 - 12:17
Ageing and infertility: unravelling the connections
Francesca Duncan, U.S.A.
12:17 - 12:47
Clinical insights: navigating age challenges in family building (speakers: Sunkara Sesh Kamal & Christos Venetis)
12:17 - 12:47
Co-speaker[0000788310] Clinical insights: navigating age challenges in family building (speakers: Sunkara Sesh Kamal & Christos Venetis)
Sesh Kamal Sunkara, United Kingdom
Co-speaker[0000788310] Clinical insights: navigating age challenges in family building
Christos Venetis, Greece
12:47 - 12:55
It takes two to tango: the redemption of the sperm
Manuela Simoni, Italy
12:55 - 13:00
Summary and conclusion remarks
Thomas D'Hooghe, Germany

11:45 - 12:45
Session 48: EU session: ESHRE & the EU: Navigating the new SoHO regulation and the EuMAR project
Chairs
Karen Sermon, Belgium
Carlos Calhaz-Jorge, Portugal
11:45 - 12:05
The New Regulation on Substances Of Human Origin (SoHO) (DG SANTE (European Commission)
Stefaan Van Der Spiegel, Belgium
12:05 - 12:15
Impact of the new SoHO regulation on ART practices
Kersti Lundin, Sweden
12:15 - 12:25
Discussion
12:25 - 12:35
The road to a European prospective cycle-by-cycle data collection: EuMAR
Christian De Geyter, Switzerland
12:35 - 12:45
Discussion

10:00 - 12:45
Session 43: Live surgery session - 20 years of live surgery
Chairs
Anis Feki, Switzerland
Georgios Pados, Greece
Michelle Nisolle, Belgium
Transvaginal endoscopy: Hysteroscopy & Laparoscopy(THL)
Ursula Catena, Italy
Attilio Di Spiezio Sardo, Italy
Rudi L. Campo, Belgium
Evy Gillet, Belgium
Stephan Gordts, Belgium
Laparoscopy
Stavros Karampelas, Greece
Helena Van Kerrebroeck, Belgium
Filipa Beja Osorio, Portugal

11:45 - 12:45
Session 49: Stem cells in reproductive medicine: from basic science to clinical applications
Chairs
Jan-Bernd Stukenborg, Sweden
Ans van Pelt, The Netherlands
11:45 - 12:05
Modelling early human development and implantation using stem cells
Thomas Freour, France
12:05 - 12:15
Discussion
12:15 - 12:35
The therapeutic potential of stem cells for ovarian rejuvenation
Emre Seli, U.S.A.
12:35 - 12:45
Discussion

11:45 - 12:45
Session 50: Third-party reproduction - how will the paradigm change counselling?
Chairs
Giuliana Baccino, Spain
Monique H. Mochtar, The Netherlands
11:45 - 12:05
Advances in oocyte freezing: implications for donors, recipients, counsellors and clinics
Nicky Hudson, United Kingdom
12:05 - 12:15
Discussion
12:15 - 12:35
The next generation of adolescents will consider more and more multiparenthood, poliparenthood
Lize Leunens, Belgium
12:35 - 12:45
Discussion

11:45 - 12:15
Session 51: FSANZ Exchange session
Chairs
Dean Morbeck, Australia
Gijs Teklenburg, The Netherlands
11:45 - 12:05
Apicobasal RNA asymmetries regulate cell fate in the early mouse embryo
Azelle Hawdon, Australia
12:05 - 12:15
Discussion

11:45 - 12:45
Session 52: Poster discussion session - Reproductive genetics
Alberto Sola-Leyva, Sweden
11:45 - 12:00
Characterization of the morphology of the outer-kinetochore expandable module, aka fibrous corona, and its role in ensuring proper chromosome segregation in human and bovine oocytes
Chiara Baggio, The Netherlands
12:00 - 12:15
Chaotic blastocysts in preimplantation genetic testing for aneuploidies: prevalence, characterization and re-biopsy results
Anna Calull Bago, Mexico
12:15 - 12:30
Application of simultaneous PGT-M/PGT-A using whole genome sequencing and haplotyping for monogenetic disorders, multiple variants, low penetrance, and de novo disorders
Svetlana Madjunkova, Canada
12:30 - 12:45
Decoding ovarian response: the predictive power of FSH receptor gene expression in controlled ovarian stimulation
Zeynep Gunes, United Kingdom

13:00 - 14:00
Lunch break in the exhibit hall

14:00 - 15:15
Gedeon Richter: Comprehensive Insights into Endometriosis: Epidemiology, Mechanisms of action and Modern Therapies
Chair
Bart C.J.M. Fauser, The Netherlands
14:00 - 14:25
In-depth Look at the Epidemiology of Endometriosis
Stacey Missmer, U.S.A.
14:25 - 14:50
Decoding Endometriosis Mechanisms and their Impact on Fertility
Edgardo Somigliana, Italy
14:50 - 15:10
A Dive into Contemporary Treatments for Endometriosis with Real-Life Clinical Cases
Stefan Renner, Germany
15:10 - 15:15
Conclusions
Bart C.J.M. Fauser, The Netherlands

14:00 - 15:00
Session 53: MHR symposium: Basic principles of human development revealed by natural embryos and stem cell-generated embryo models
Chairs
Michele Boiani, Germany
Francesca Duncan, U.S.A.
14:00 - 14:20
Live imaging reveals key events in preimplantation embryo development
Robin Skory, U.S.A.
14:20 - 14:30
Discussion
14:30 - 14:50
Gastruloids: a pluripotent stem cell model of gastrulation and body plan engineering in development and disease
Alfonso Martinez-Arias, Spain
14:50 - 15:00
Discussion

14:00 - 15:00
Session 54: Sustainability in the ART lab - essential, but is it feasible?
Chairs
Maria Jose De Los Santos, Spain
Marjoleine Louwerse, The Netherlands
14:00 - 14:20
Marginal gains: can small actions in the ART lab improve the environmental impact of medically assisted reproduction?
Francesca Farlie, United Kingdom
14:20 - 14:30
Discussion
14:30 - 14:50
Ethical practices and policies for ART carbon reduction
Cristina Richie, United Kingdom
14:50 - 15:00
Discussion

14:00 - 15:00
Session 55: Pregnancy loss: the emotional toll for parents and providers
Chairs
Karen Henriette Kirchheiner Jensen, Denmark
Marie-Louise van der Hoorn, The Netherlands
14:00 - 14:20
Hoping for the best, expecting the worst: pregnancy after loss
Jacky Boivin, United Kingdom
14:20 - 14:30
Discussion
14:30 - 14:50
Emotional experiences of staff caring for parents suffering a pregnancy loss
Johnson Judith, United Kingdom
14:50 - 15:00
Discussion
15:00 - 15:10
Empowering excellence: Elevating Fertility Nursing Practice through ESHRE’s Certification.
Valerie Peddie, United Kingdom

14:00 - 15:00
Session 56: Patient session: Donation: a 360° view
Chairs
Karianne Bye, Norway
Monika Bulmanska-Wingett, United Kingdom
14:00 - 14:15
From secrecy to transparency: The journey of donor identity in reproductive medicine in Portugal
Ana Galhardo, Portugal
14:15 - 14:20
Discussion
14:20 - 14:35
On being whole – fantasy and the unthought known
Timo Ramu, Finland
14:35 - 14:40
Discussion
14:40 - 14:55
It takes more than genes to build a family
Maciej Śmiechowski, Poland
14:55 - 15:00
Discussion

14:00 - 15:00
Session 57: To err is human: building a safer fertility clinic
Chairs
Rita Vassena, Spain
Anja Pinborg, Denmark
14:00 - 14:20
To err is human, also for those working in ART
Alessandra Alteri, Italy
14:20 - 14:30
Discussion
14:30 - 14:50
Building a safer fertility clinic
Kelly Tilleman, Belgium
14:50 - 15:00
Discussion

14:00 - 15:00
Session 58: Poster discussion session - GSCAIF
Miray Nilufer Cimsit Kemahli, Turkey
14:00 - 14:15
Prevalence of chromosomal abnormalities in oocyte donor candidates: a French survey of over 8200 karyotypes
Vincent Puy, France
14:15 - 14:30
Egg-conomized frozen embryo transfer
Femke Mol, The Netherlands
14:30 - 14:45
Proposal of model to calculate the trend in the cumulative live birth rate in IVF cycles using Spanish National Register data from 2009 to 2021
Rocio Nunez - Calonge, Spain
14:45 - 15:00
Risk of placenta previa in assisted reproduction: population study with sibling analyses from the committee of nordic ART and safety
Eirik Landsverk, Norway

14:45 - 15:45
Besins Healthcare: Unravelling the "Black Box" in Luteal Phase Support
Chairs
Peter Humaidan, Denmark
Frank J. Broekmans, The Netherlands
14:45 - 15:00
Introduction by the Chairmen
15:00 - 15:15
State of the Art in Luteal Phase Support
Dominic Stoop, Belgium
15:15 - 15:30
Natural Proliferative Phase: A New Era in FET Cycles
Samuel Dos Santos-Ribeiro, Portugal
15:30 - 15:45
Questions and Conclusions by the Chairmen

15:15 - 16:30
Session 59: Can insemination techniques be improved?
Chairs
Thomas Ebner, Austria
Kaylee Holleman, The Netherlands
15:15 - 15:30
Piezo-ICSI reduces oocyte degeneration, improves ICSI success rates and has shown less dependence on the experience level of embryologists: cumulative data with 65,033 MII oocytes
Hideaki Watanabe, Japan
15:30 - 15:45
Far away so close: remote ICSI using an AI-powered robot
Gerardo Mendizabal, Mexico
15:45 - 16:00
A novel micro-insemination method, assisted sperm fusion insemination, increases the embryo utilization rate compared to conventional intracytoplasmic sperm injection
Shota Hatakeyama, Japan
16:00 - 16:15
Real-word data on effectiveness of ICSI over conventional IVF according to infertility factors based on Human Fertilisation and Embryology Authority dataset.
Paola Vigano, Italy
16:15 - 16:30
Conventional in vitro fertilisation versus intracytoplasmic sperm injection in first cycle patients without severe male factor infertility (INVICSI): a randomised, controlled, open-label, multicentre trial
Sine Berntsen, Denmark

15:15 - 16:30
Session 60: Rethinking PCOS
Chairs
Gurkan Bozdag, Turkey
Jan-Peter de Bruin, The Netherlands
15:15 - 15:30
Letrozole-resistant PCOS: prevalence, further options and course of fertility treatment
Sujoy Dasgupta, India
15:30 - 15:45
Hormone-free versus FSH-primed infertility treatment of women with polycystic ovary syndrome using biphasic in vitro maturation: a randomised clinical trial
Lan N Vuong, Vietnam
15:45 - 16:00
Delayed fetal growth in pregnant women with polycystic ovary syndrome using serial ultrasonographic biometry
Fangfang Wang, China
16:00 - 16:15
Kisspeptin as a test of hypothalamic function in women presenting with oligo-amenorrhea
Arthur Yeung, United Kingdom
16:15 - 16:30
Age-related normograms of AMH in women with polycystic ovary syndrome using three different assays
FEDERICA BARBAGALLO, Italy

15:15 - 16:30
Session 61: Sperm quality and ART outcomes
Chairs
Nathalie Rives, France
Sandra Tanahatoe, The Netherlands
15:15 - 15:30
Cumulative live birth and neonatal outcomes according to different male factors in IVF/ICSI cycles
Liu Jiang, China
15:30 - 15:45
Decreased embryo developmental potential and lower cumulative pregnancy rate in males with multiple morphological abnormalities of the sperm flagella
Rui Long, China
15:45 - 16:00
Men who fathered embryos with poor pre-implantation development rates exhibit an increased frequency of sperm with high DNA accessibility
Mark E. Gill, Switzerland
16:00 - 16:15
Correlation of intracellular pH of non-normozoospermic men with fertilization rates in assisted reproduction procedures (Pilot study)
Gabriela Carrasquel Martínez, Mexico
16:15 - 16:30
The decline in semen quality parameters enhances mosaicism in trophectoderm biopsy of human blastocysts
Davaakhuu Sengebaljir, Mongolia

15:15 - 16:30
Session 62: Advancements in implantation and early pregnancy
Chairs
Danilo Cimadomo, Italy
Annemarie G.M.G.J. Mulders, The Netherlands
15:15 - 15:30
IVF Success Rates: Challenging the Concept of Recurrent Implantation Failure
Kilian Vomstein, Denmark
15:30 - 15:45
Association between proton pump inhibitors use and the risk of maternal infections during pregnancy and postpartum: A Swedish population-based cohort study
Hana Shabana, Sweden
15:45 - 16:00
Antinuclear antibodies in women with recurrent early pregnancy loss: prevalence and impact on subsequent pregnancy outcome
Valerie Uvin, Belgium
16:00 - 16:15
Novel use of Hyaluronan Enriched Media for Improving Implantation in Intrauterine Insemination: A Prospective Randomised Controlled Trial (HEMI Trial)
Navdeep Kaur Ghuman, India
16:15 - 16:30
Comparing viable and non-viable IVF early pregnancy measurements: Does knowledge of gestational age using date of et potentially change miscarriage diagnosis guidelines in IVF patients
Sughashini Murugesu, United Kingdom

15:15 - 16:30
Session 63: Endometrial support strategies - what do the studies say?
Chairs
Baris Ata, United Arab Emirates
Femi Janse, The Netherlands
15:15 - 15:30
Optimal timing and endometrial preparation in modified natural cycle (mNC) frozen embryo transfer (FET) cycles: The FET OPTIMIZING randomised controlled trial
Marte Saupstad, Denmark
15:30 - 15:45
Dydrogesterone versus micronized vaginal progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer cycles (REMODEL): an exploratory randomized controlled trial.
Caroline Roelens, Belgium
15:45 - 16:00
Natural, modified natural or artificial endometrial preparation strategies for frozen embryo transfer in ovulatory women (MONART): a randomized controlled trial
Vu Ngoc Anh Ho, Vietnam
16:00 - 16:15
Comparison of the pregnancy outcomes of transferring frozen embryos versus fresh embryos among advanced maternal age women: A nationwide analysis of 232,942 cycles
Zhilong Wang, China
16:15 - 16:30
The Programmed Ovulatory Frozen-Thawed Embryo Transfer Cycle (PO-FET): a suggested FET protocol integrating aspects of embryo transfer scheduling, efficacy optimization and maternal/fetal safety
Tanja K. Eggersmann, Germany

15:15 - 16:30
Session 64: Safety and quality from embryo to offspring
Chairs
Alessandra Alteri, Italy
Aleksej Stevanovic, Norway
15:15 - 15:30
Identifying toxicity trends: analysis of over 6700 Mouse Embryo Assays performed on 16 categories of IVF supplies
Albert Martínez-Casado, Spain
15:30 - 15:45
DNA methylation signature of monozygotic twinning: investigating the relationship with medically assisted reproduction, higher-order gestations, and common genetic variants
Jenny Van Dongen, The Netherlands
15:45 - 16:00
Exploring risk factors of mismatch in the ART laboratory: An analysis based on 73719 electronic witnessing points
Yanhe Liu, Australia
16:00 - 16:15
A need to standardize: The use and posterior recall of toxic consumables could be avoided with the appropriate testing protocols
Enric Mestres, Spain
16:15 - 16:30
Analysis of risk factors for monozygotic twins following in vitro fertilization-embryo transfer
Mingxia Gao, China

15:15 - 16:30
Session 65: Poster discussion session - Embryology
Sofia Makieva, Switzerland
15:15 - 15:30
Deep sequencing of spermatozoal accessible chromatin reveals complex arrangements underlying spermatozoal chromatin packaging and fertilization
David Iles, United Kingdom
15:30 - 15:42
Early blastocyst formation on day 4 is associated with improved clinical outcome and advocates for embryo quailty assessment on day 4.
Sophie Loubersac, France
15:42 - 15:52
Structural changes of the human sperm tail during the early post-fertilization
Yoshiteru Kai, Japan
15:52 - 16:04
Image-based oocyte model predictive of blastocyst development correlates with ploidy status across a broad spectrum of PGT-A indications, accounting for confounding variables
Jonas Malmsten, U.S.A.
16:05 - 16:17
Does assessment of time-lapse videos result in improved prediction of clinical pregnancy compared to assessment of single images of blastocysts?
Yuta Kida, Japan
16:17 - 16:30
Number of autologous mature oocytes as a predictor of live birth rate in women aged over 40 who do not accept egg donation
Maria Pia Zappacosta Villarroel, Argentina

16:30 - 17:00
Coffee break in the exhibit hall

16:45 - 18:00
Organon LLC: Meeting the needs of your patients: The right approaches in the clinic and the lab to deliver the results desired.
Chair
Keith Gordon, U.S.A.
16:45 - 17:45
Lecture The Clinical Approach
Juan A. Garcia-Velasco, Spain
16:45 - 17:45
Lecture The Lab Approach
Mina Popovic, Spain

17:00 - 18:00
Session 66: Unraveling the influence: external factors impacting outcomes
Chairs
Carlos Plancha, Portugal
Koen van Zomeren, The Netherlands
17:00 - 17:15
The Effect of Constant 5% Versus Gradient 8%, 5%, 2% Oxygen Concentration on the Development of Sibling Human Embryos in Vitro to the Blastocyst Stage
Peter Slatinsek, Slovenia
17:15 - 17:30
Copper oxide nanoparticles impair embryo development through mitophagy-mediated metabolism
JINGYU LI, China
17:30 - 17:45
The impact of maternal age on cumulative life birth rates after single euploid embryo transfer: differences between autologous and donor oocyte cycles
Ilaria Listorti, Italy
17:45 - 18:00
Evaluating the impact of obesity on oocyte quality, using 2 main factors in cumulus cells (CC) and follicular fluid (FF) which reflect oocyte quality
Emiliya Sigal, Israel

17:00 - 18:00
Session 67: Artificial intelligence - the state of the ART
Chairs
George Lainas, Greece
Tjitske Zaat, The Netherlands
17:00 - 17:15
Prospective validation of an artificial intelligence platform for automated follicle counting
Piotr Wygocki, Poland
17:15 - 17:30
Explainable artificial intelligence (XAI) to determine the follicle sizes on trigger day that maximize mature oocyte yield
Simon Hanassab, United Kingdom
17:30 - 17:45
Ovarify: a deep learning model for automatic calculation of ovarian morphological features in pelvic ultrasonography
Eeshaan Rehani, U.S.A.
17:45 - 18:00
An interpretable deep learning model for predicting the number of mature oocytes retrieved after ovarian hyperstimulation
Or Shafran, Israel

17:00 - 18:00
Session 68: Third party reproduction: from decision to disclosure
Chairs
Mariana Moura-Ramos, Portugal
Marieke Schoonenberg, The Netherlands
17:00 - 17:15
The impact of psychological counselling on decision-making of sperm donation among the couples with nonobstructive azoospermia after unsuccessful microdissection testicular sperm extraction
Tomoe Koizumi, Japan
17:15 - 17:30
Can the theory of planned behavior predict parents’ disclosure of donor conception to their children within 5-9 years?
Claudia Lampic, Sweden
17:30 - 17:45
"There might be two hundreds of us" - A qualitative study on the experience of meeting large numbers of same donor offspring
Sabrina Zeghiche, Canada
17:45 - 18:00
A study investigating whether egg share donors treatment outcome impacted on their overall psychological well-being and treatment experience
Tim Bracewell-Milnes, United Kingdom

17:00 - 18:00
Session 69: Reproductive surgery
Chairs
Jean Marc Ayoubi, France
Judith Rikken, The Netherlands
17:00 - 17:15
Effects of preventive uterine artery occlusion during laparoscopic myomectomy on ovarian reserve markers: a randomized controlled trial.
Isabelle Streuli, Switzerland
17:15 - 17:30
First successful ovary allotransplants to Turner’s syndrome patients requiring immunosuppression
Sherman J. Silber, U.S.A.
17:30 - 17:45
Do myomectomies decrease third trimester pregnancy complications when compared to women without myomectomies and uterine fibroids in situ? A study of an American population database.
perrine ginod, Canada
17:45 - 18:00
Neck scarf of ureter and Intraoperative ICG-fluorescence for preventing ureters injuries in Da Vinci Robotic deep infiltrating endometriosis excision.
Yi-Chen Chuang, Taiwan R.O.C.

17:00 - 18:00
Session 70: Ethics, information, and choice in medically assisted reproduction
Chairs
Nicola Williams, United Kingdom
Ana Pereira Daoud, The Netherlands
17:00 - 17:15
The ethics of disclosing reported conditions in donor-conceived offspring to recipients of the same donor
Dorian Accoe, Belgium
17:15 - 17:30
Offering and regulating expanded carrier screening (ECS) in the UK: an exciting prospect in genetic testing or ‘a can of worms’?
Cathy Herbrand, United Kingdom
17:30 - 17:45
New principles for the use of artificial intelligence in human reproduction: leave everything as it is?
Michiel De Proost, Belgium
17:45 - 18:00
The current landscape for carrier screening in donor conception; a game of chance for donors and recipients?
Colleen Lynch, United Kingdom

17:00 - 18:00
Session 71: Poster discussion session - Endometriosis & endometrial disorders
Celine Bafort, Belgium
17:00 - 17:15
Relugolix combination therapy vs relugolix monotherapy with transition to relugolix combination therapy for the treatment of endometriosis-associated pain: implications for cumulative benefit/risk profile
Christian Becker, United Kingdom
17:15 - 17:30
Finding on the gut microbiome impact on non-reproductive pathologies of the uterus: an endometriosis perspective
Antonio Martinez Lara, Spain
17:30 - 17:45
Enhancing endometrial thickness and implantation rates: a study on the effectiveness of autologous blood cell derivative - endosera in infertile women with thin endometrium
Nandita Palshetkar, India
17:45 - 18:00
Spatial transcriptomics identifies dysregulated pathways in adenomyosis proposing potential re-purposed lesion-specific treatments
Alison Maclean, United Kingdom

18:00 - 19:00
Annual General Assembly of Members
GA
Bruno Van Den Eede, Belgium

13:00 - 14:00
SIG Nurses and Midwives members' meeting
SIGNM members meeting
Louise Dias, Belgium

09:00 - 11:00
Fertility Europe meeting

09:00 - 11:00
WG on Good practice for IVF labs

10:00 - 10:30
CSAO/FSANZ Award Committee meeting

11:00 - 12:00
ESHRE-CSRM meeting

11:00 - 13:30
NMCC Committee meeting Part 2

11:30 - 14:00
FeRGI meeting

12:00 - 14:00
Human Reproduction Update Associate Editors' meeting

12:00 - 14:00
Human Reproduction Open Associate Editors' meeting

13:00 - 14:00
ESHRE/ASRM Liaison Committee meeting

13:00 - 14:00
Ethics Committee meeting

13:00 - 14:00
SIG Reproductive Genetics Steering Committee Meeting

13:00 - 14:00
Women's Health Research Centre meeting

13:00 - 14:00
BSAO Award Committee meeting

13:00 - 15:00
ECRES Committee meeting

13:00 - 16:00
EIM Consortium General Assembly meeting

13:00 - 18:00
Cochrane meeting

14:00 - 15:00
ESHRE-REDLARA meeting

15:00 - 16:00
Nurses Award Committee meeting

15:00 - 17:00
Adenomyosis working group meeting

15:30 - 18:00
Fertility Europe meeting

16:30 - 17:00
BSAP Award Committee meeting

16:30 - 17:00
CSAP Award Committee meeting

16:30 - 17:15
Vitrolife Group & ESHRE Chairs meeting

17:00 - 19:00
Pre-conception care kick-off meeting